HUE055904T2 - 2-([1,2,3]triazol-2-il)-benzoesav-származékok elõállítása - Google Patents

2-([1,2,3]triazol-2-il)-benzoesav-származékok elõállítása

Info

Publication number
HUE055904T2
HUE055904T2 HUE18722948A HUE18722948A HUE055904T2 HU E055904 T2 HUE055904 T2 HU E055904T2 HU E18722948 A HUE18722948 A HU E18722948A HU E18722948 A HUE18722948 A HU E18722948A HU E055904 T2 HUE055904 T2 HU E055904T2
Authority
HU
Hungary
Prior art keywords
triazol
preparation
benzoic acid
acid derivatives
derivatives
Prior art date
Application number
HUE18722948A
Other languages
English (en)
Inventor
Patric Doerrwächter
Gunther Schmidt
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of HUE055904T2 publication Critical patent/HUE055904T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/70Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
    • B01J23/72Copper
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HUE18722948A 2017-05-03 2018-05-02 2-([1,2,3]triazol-2-il)-benzoesav-származékok elõállítása HUE055904T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2017060451 2017-05-03

Publications (1)

Publication Number Publication Date
HUE055904T2 true HUE055904T2 (hu) 2021-12-28

Family

ID=62116854

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18722948A HUE055904T2 (hu) 2017-05-03 2018-05-02 2-([1,2,3]triazol-2-il)-benzoesav-származékok elõállítása

Country Status (20)

Country Link
US (1) US11124488B2 (hu)
EP (1) EP3619199B1 (hu)
JP (1) JP7182562B2 (hu)
KR (1) KR102582197B1 (hu)
CN (1) CN110612291B (hu)
CA (1) CA3059394C (hu)
CY (1) CY1124777T1 (hu)
DK (1) DK3619199T3 (hu)
ES (1) ES2892161T3 (hu)
HR (1) HRP20211304T1 (hu)
HU (1) HUE055904T2 (hu)
IL (1) IL270274B (hu)
LT (1) LT3619199T (hu)
MX (1) MX2019012902A (hu)
PL (1) PL3619199T3 (hu)
PT (1) PT3619199T (hu)
RS (1) RS62357B1 (hu)
SI (1) SI3619199T1 (hu)
TW (1) TWI756418B (hu)
WO (1) WO2018202689A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022020924A2 (pt) 2020-04-19 2023-02-14 Idorsia Pharmaceuticals Ltd Métodos de tratamento de um transtorno do sono, a sonolência diurna em um indivíduo, a insônia, e, daridorexante na forma de sal livre ou farmaceuticamente aceitável
WO2023218023A1 (en) 2022-05-13 2023-11-16 Idorsia Pharmaceuticals Ltd Thiazoloaryl-methyl substituted cyclic hydrazine-n-carboxamide derivatives

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2069332B1 (en) 2006-08-15 2011-03-02 Actelion Pharmaceuticals Ltd. Azetidine compounds as orexin receptor antagonists
TW200823227A (en) 2006-09-29 2008-06-01 Actelion Pharmaceuticals Ltd 3-aza-bicyclo[3.1.0]hexane derivatives
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
AR064561A1 (es) 2006-12-28 2009-04-08 Actelion Pharmaceuticals Ltd Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina.
US20100222328A1 (en) 2007-05-14 2010-09-02 Hamed Aissaoui 2-cyclopropyl-thiazole derivatives
JP2010528007A (ja) 2007-05-23 2010-08-19 メルク・シャープ・エンド・ドーム・コーポレイション シクロプロピルピロリジンオレキシン受容体アンタゴニスト
PL2491038T3 (pl) 2009-10-23 2016-10-31 Dwupodstawione oktahydropirolo[3,4-c]pirole jako modulatory receptora oreksyny
EP2491034B1 (en) 2009-10-23 2013-12-18 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as orexin receptor modulators
EP2491031B1 (en) 2009-10-23 2013-08-07 Janssen Pharmaceutica N.V. Fused heterocyclic compounds as orexin receptor modulators
EP2653469A4 (en) 2010-12-17 2014-05-07 Taisho Pharmaceutical Co Ltd pyrazole
WO2012085857A1 (en) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-3-yl amides
EP2680697B1 (en) 2011-03-03 2018-01-10 Merck Sharp & Dohme Corp. Process for the preparation of an orexin receptor antagonist
WO2012145581A1 (en) 2011-04-20 2012-10-26 Janssen Pharmaceutica Nv Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
TW201315730A (zh) 2011-07-05 2013-04-16 大正製藥股份有限公司 甲基哌啶衍生物
WO2013050938A1 (en) * 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
TWI555747B (zh) 2011-11-08 2016-11-01 艾克泰聯製藥有限公司 2-(1,2,3-三唑-2-基)苯甲醯胺及3-(1,2,3-三唑-2-基)吡啶醯胺衍生物
EP2847343A4 (en) 2012-05-09 2016-04-06 Merck Sharp & Dohme METHOD FOR PREPARING AN INTERMEDIATE FOR AN OREXIN RECEPTOR ANTAGONIST
SG10201702540UA (en) 2012-06-04 2017-05-30 Actelion Pharmaceuticals Ltd Benzimidazole-proline derivatives
JP2014015452A (ja) 2012-06-15 2014-01-30 Taisho Pharmaceutical Co Ltd ピラゾール誘導体を含有する医薬
JP6244365B2 (ja) 2012-10-10 2017-12-06 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd [オルトビ−(ヘテロ−)アリール]−[2−(メタビ−(ヘテロ−)アリール)−ピロリジン−1−イル]−メタノン誘導体であるオレキシン受容体アンタゴニスト
US9403813B2 (en) 2013-03-12 2016-08-02 Actelion Pharmaceuticals Ltd. Azetidine amide derivatives as orexin receptor antagonists
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
AU2014358742B2 (en) * 2013-12-03 2019-02-07 Idorsia Pharmaceuticals Ltd Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
ES2696708T3 (es) 2013-12-04 2019-01-17 Idorsia Pharmaceuticals Ltd Uso de derivados de bencimidazol-prolina
TW201613891A (en) * 2014-02-12 2016-04-16 Eolas Therapeutics Inc Substituted prolines / piperidines as orexin receptor antagonists
WO2016020403A1 (en) 2014-08-04 2016-02-11 Sandoz Ag Preparation of a benzoic acid derivative and its use for the preparation of suvorexant
CN104649983B (zh) * 2014-12-23 2018-01-23 广东东阳光药业有限公司 一种酸的制备方法
US10131653B2 (en) * 2015-04-24 2018-11-20 Takeda Pharmaceutical Company Limited Heterocyclic compound

Also Published As

Publication number Publication date
EP3619199A1 (en) 2020-03-11
CN110612291A (zh) 2019-12-24
SI3619199T1 (sl) 2021-11-30
PL3619199T3 (pl) 2021-12-20
US20210114997A1 (en) 2021-04-22
TW201843144A (zh) 2018-12-16
RS62357B1 (sr) 2021-10-29
CY1124777T1 (el) 2022-11-25
IL270274B (en) 2022-08-01
JP2020518573A (ja) 2020-06-25
HRP20211304T1 (hr) 2021-11-12
IL270274A (hu) 2019-12-31
KR20200003097A (ko) 2020-01-08
PT3619199T (pt) 2021-10-01
US11124488B2 (en) 2021-09-21
DK3619199T3 (da) 2021-09-27
KR102582197B1 (ko) 2023-09-22
EP3619199B1 (en) 2021-07-07
CA3059394C (en) 2023-09-12
ES2892161T3 (es) 2022-02-02
LT3619199T (lt) 2021-09-27
JP7182562B2 (ja) 2022-12-02
MX2019012902A (es) 2019-12-16
CA3059394A1 (en) 2018-11-08
WO2018202689A1 (en) 2018-11-08
TWI756418B (zh) 2022-03-01
CN110612291B (zh) 2024-02-13

Similar Documents

Publication Publication Date Title
EP3402787A4 (en) PROCESSES FOR PREPARING 2,5-FURANDICARBOXYLIC ACID AND INTERMEDIATES AND DERIVATIVES THEREOF
HUE065368T2 (hu) Eljárás 2,5-furándikabonsav és származékai elõállítására
EP3370728A4 (en) PROCESS FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF
EP3480198A4 (en) NEW COMPOUND OR ITS PHARMACEUTICALLY ACCEPTED SALT
EP3679945A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITION
IL260011B (en) History of water-soluble 5,3-diphenyldiazole compounds
IL271399A (en) Methods for the preparation of heterocyclic 3,1-benzodioxole compounds
EP3384772A4 (en) AGROCHEMICAL COMPOSITION IN AQUEOUS SUSPENSION
EP3315492A4 (en) Pyrazole derivative, or pharmaceutically acceptable salt thereof
EP3490978A4 (en) SALTS OF 2, 6-DIMETHYLPYRIMIDONE DERIVATIVES AND THEIR USES
EP3445370A4 (en) PROCESSES FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF
EP3442943A4 (en) AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND / OR ANTICANCER AGENTS
MX2020012771A (es) Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.
PT3619199T (pt) Preparação de derivados de ácido 2-([1,2,3]triazol-2-il)- benzoico
HK1256825A1 (zh) 取代的5,6-二氫-6-苯基苯並[f]異喹啉-2-胺化合物的固體形式
EP3530654A4 (en) CARBOXYLIC ACID COMPOUND WITH QUINOLINYL SUBSTITUTE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3189842A4 (en) Composition for preventing hair loss or promoting hair growth, containing oleanolic acid derivative and pharmaceutically acceptable salt thereof
HK1258757A1 (zh) 4H-吡唑並[1,5-α]苯並咪唑類化合物的鹽型、晶型及其製備方法和中間體
EP3699250A4 (en) COMPOSITION PROVIDING A FRESHNESS FEELING CONTAINING A DERIVATIVE OF 2,2,6-TRIMETHYLCYLCYCLOHEXANECARBOXYLIC ACID
IL254578A0 (en) Abscisic acid (s)-2' vinyl derivatives
EP3398946A4 (en) SALT OF MORPHOLINE DERIVATIVE AND ITS CRYSTALLINE FORM, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3436439A4 (en) METHOD FOR PRODUCING DIPHENYLPYRAZINE DERIVATIVES
EP3166405A4 (en) 3'-substituted-abscisic acid derivatives
EP3856732C0 (en) PROCESS AND SALTS FOR THE PREPARATION OF 2,5-FURANEDICARBOXYLIC ACID
EP3177592A4 (en) Process for the preparation of 4,5,6-trichloropicolinic acid